Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shock
- 1 August 2005
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 70 (4), 535-544
- https://doi.org/10.1016/j.bcp.2005.04.047
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Generation of Glycosylated Remnant Epitopes from Human Collagen Type II by Gelatinase BBiochemistry, 2004
- Increased Susceptibility to LPS-induced Endotoxin Shock in Secretory Leukoprotease Inhibitor (SLPI)-deficient MiceThe Journal of Experimental Medicine, 2003
- Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritisThe FASEB Journal, 2002
- Regulation of Matrix Metalloproteinases and Their Inhibitor Genes in Lipopolysaccharide-Induced Endotoxemia in MiceThe American Journal of Pathology, 2000
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- A MATRIX METALLOPROTEINASE INHIBITOR PREVENTS PROCESSING OF TUMOR NECROSIS FACTOR α (TNFα) AND ABROGATES ENDOTOXIN-INDUCED LETHALITYShock, 1997
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Purification and identification of 91‐kDa neutrophil gelatinaseEuropean Journal of Biochemistry, 1991
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989